FDA Announces Joint Meeting of Arthritis Advisory Committee and Drug Safety Advisory Committee

Summary

The FDA is hosting a joint meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee, where the committees will provide advice on regulatory issues, and the public can submit comments on the meeting and its agenda.